153 related articles for article (PubMed ID: 25394852)
1. Glycolysis inhibitor 2-deoxy-D-glucose suppresses carcinogen-induced rat hepatocarcinogenesis by restricting cancer cell metabolism.
Wang Z; Zhang L; Zhang D; Sun R; Wang Q; Liu X
Mol Med Rep; 2015 Mar; 11(3):1917-24. PubMed ID: 25394852
[TBL] [Abstract][Full Text] [Related]
2. Co-treatment of breast cancer cells with pharmacologic doses of 2-deoxy-D-glucose and metformin: Starving tumors.
Wokoun U; Hellriegel M; Emons G; Gründker C
Oncol Rep; 2017 Apr; 37(4):2418-2424. PubMed ID: 28350075
[TBL] [Abstract][Full Text] [Related]
3. 2-Deoxyglucose induces the expression of thioredoxin interacting protein (TXNIP) by increasing O-GlcNAcylation - Implications for targeting the Warburg effect in cancer cells.
Hong SY; Hagen T
Biochem Biophys Res Commun; 2015 Oct; 465(4):838-44. PubMed ID: 26315267
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of the glycolysis inhibitor 2-deoxy-D-glucose on the activity of pro-apoptotic agents in metastatic melanoma cells, and induction of a cytoprotective autophagic response.
Giammarioli AM; Gambardella L; Barbati C; Pietraforte D; Tinari A; Alberton M; Gnessi L; Griffin RJ; Minetti M; Malorni W
Int J Cancer; 2012 Aug; 131(4):E337-47. PubMed ID: 21913183
[TBL] [Abstract][Full Text] [Related]
5. Dihydroartemisinin inhibits glucose uptake and cooperates with glycolysis inhibitor to induce apoptosis in non-small cell lung carcinoma cells.
Mi YJ; Geng GJ; Zou ZZ; Gao J; Luo XY; Liu Y; Li N; Li CL; Chen YQ; Yu XY; Jiang J
PLoS One; 2015; 10(3):e0120426. PubMed ID: 25799586
[TBL] [Abstract][Full Text] [Related]
6. Synergism of ursolic acid derivative US597 with 2-deoxy-D-glucose to preferentially induce tumor cell death by dual-targeting of apoptosis and glycolysis.
Wang J; Jiang Z; Xiang L; Li Y; Ou M; Yang X; Shao J; Lu Y; Lin L; Chen J; Dai Y; Jia L
Sci Rep; 2014 May; 4():5006. PubMed ID: 25833312
[TBL] [Abstract][Full Text] [Related]
7. Proliferation enhanced by NGF-NTRK1 signaling makes pancreatic cancer cells more sensitive to 2DG-induced apoptosis.
Cheng Y; Diao DM; Zhang H; Song YC; Dang CX
Int J Med Sci; 2013; 10(5):634-40. PubMed ID: 23569426
[TBL] [Abstract][Full Text] [Related]
8. Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells.
Ben Sahra I; Laurent K; Giuliano S; Larbret F; Ponzio G; Gounon P; Le Marchand-Brustel Y; Giorgetti-Peraldi S; Cormont M; Bertolotto C; Deckert M; Auberger P; Tanti JF; Bost F
Cancer Res; 2010 Mar; 70(6):2465-75. PubMed ID: 20215500
[TBL] [Abstract][Full Text] [Related]
9. 2-Deoxyglucose Reverses the Promoting Effect of Insulin on Colorectal Cancer Cells In Vitro.
Zhang D; Fei Q; Li J; Zhang C; Sun Y; Zhu C; Wang F; Sun Y
PLoS One; 2016; 11(3):e0151115. PubMed ID: 26939025
[TBL] [Abstract][Full Text] [Related]
10. Differences in glycolytic capacity and hypoxia tolerance between hepatoma cells and hepatocytes.
Hugo-Wissemann D; Anundi I; Lauchart W; Viebahn R; de Groot H
Hepatology; 1991 Feb; 13(2):297-303. PubMed ID: 1847350
[TBL] [Abstract][Full Text] [Related]
11. Starving tumors: inhibition of glycolysis reduces viability of human endometrial and ovarian cancer cells and enhances antitumor efficacy of GnRH receptor-targeted therapies.
Reutter M; Emons G; Gründker C
Int J Gynecol Cancer; 2013 Jan; 23(1):34-40. PubMed ID: 23154267
[TBL] [Abstract][Full Text] [Related]
12. 2-Deoxyglucose induces cell cycle arrest and apoptosisin colorectal cancer cells independent of its glycolysis inhibition.
Muley P; Olinger A; Tummala H
Nutr Cancer; 2015; 67(3):514-22. PubMed ID: 25751508
[TBL] [Abstract][Full Text] [Related]
13. Ifosfamide metabolite chloroacetaldehyde inhibits cell proliferation and glucose metabolism without decreasing cellular ATP content in human breast cancer cells MCF-7.
Knouzy B; Dubourg L; Baverel G; Michoudet C
J Appl Toxicol; 2010 Apr; 30(3):204-11. PubMed ID: 19774546
[TBL] [Abstract][Full Text] [Related]
14. Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer.
Li C; Zhang G; Zhao L; Ma Z; Chen H
World J Surg Oncol; 2016 Jan; 14(1):15. PubMed ID: 26791262
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of thioredoxin-1 enhances the toxicity of glycolysis inhibitor 2-deoxyglucose by downregulating SLC1A5 expression in colorectal cancer cells.
Tang T; Fang D; Ji Z; Zhong Z; Zhou B; Ye L; Jiang L; Sun X
Cell Oncol (Dordr); 2024 Apr; 47(2):607-621. PubMed ID: 37867183
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid-related orphan receptor alpha reprograms glucose metabolism in glutamine-deficient hepatoma cells.
Byun JK; Choi YK; Kang YN; Jang BK; Kang KJ; Jeon YH; Lee HW; Jeon JH; Koo SH; Jeong WI; Harris RA; Lee IK; Park KG
Hepatology; 2015 Mar; 61(3):953-64. PubMed ID: 25346526
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of 2-halogen substituted D-glucose analogs in blocking glycolysis and killing "hypoxic tumor cells".
Lampidis TJ; Kurtoglu M; Maher JC; Liu H; Krishan A; Sheft V; Szymanski S; Fokt I; Rudnicki WR; Ginalski K; Lesyng B; Priebe W
Cancer Chemother Pharmacol; 2006 Dec; 58(6):725-34. PubMed ID: 16555088
[TBL] [Abstract][Full Text] [Related]
18. Hexachlorobenzene induces cell proliferation, and aryl hydrocarbon receptor expression (AhR) in rat liver preneoplastic foci, and in the human hepatoma cell line HepG2. AhR is a mediator of ERK1/2 signaling, and cell cycle regulation in HCB-treated HepG2 cells.
de Tomaso Portaz AC; Caimi GR; Sánchez M; Chiappini F; Randi AS; Kleiman de Pisarev DL; Alvarez L
Toxicology; 2015 Oct; 336():36-47. PubMed ID: 26219504
[TBL] [Abstract][Full Text] [Related]
19. 2-Deoxy-D-glucose enhances sensitivity of human histiocytic lymphoma U937 cells to apoptosis induced by tumor necrosis factor.
Halicka HD; Ardelt B; Li X; Melamed MM; Darzynkiewicz Z
Cancer Res; 1995 Jan; 55(2):444-9. PubMed ID: 7812976
[TBL] [Abstract][Full Text] [Related]
20. Synergistic Anticancer Action of Lysosomal Membrane Permeabilization and Glycolysis Inhibition.
Kosic M; Arsikin-Csordas K; Paunovic V; Firestone RA; Ristic B; Mircic A; Petricevic S; Bosnjak M; Zogovic N; Mandic M; Bumbasirevic V; Trajkovic V; Harhaji-Trajkovic L
J Biol Chem; 2016 Oct; 291(44):22936-22948. PubMed ID: 27587392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
